tiprankstipranks
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (HK:2502)
:2502
Hong Kong Market
Want to see HK:2502 full AI Analyst Report?

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) AI Stock Analysis

0 Followers

Top Page

HK:2502

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H

(2502)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
HK$0.60
▲(40.47% Upside)
Action:ReiteratedDate:04/30/26
The score is driven primarily by weakened financial performance (losses and margin compression), partially offset by a reasonably supported balance sheet and still-positive operating cash flow. Technicals are mixed (above key moving averages but negative MACD and weak RSI), while valuation is constrained by a negative P/E and no dividend yield data.
Positive Factors
Balance-sheet resilience
Moderate leverage and sizeable equity provide a durable capital cushion that supports working capital, supplier confidence and access to credit. Over a 2–6 month horizon this positioning helps absorb earnings volatility and funds routine capex or restructuring without immediate solvency pressure.
Negative Factors
Declining revenue
Sustained top-line contraction reduces scale benefits and puts structural pressure on margins and fixed-cost absorption. If demand or pricing weakness persists beyond a quarter or two, the company will face diminished cash conversion, lower bargaining power, and harder trade-offs between investment and cost cutting.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet resilience
Moderate leverage and sizeable equity provide a durable capital cushion that supports working capital, supplier confidence and access to credit. Over a 2–6 month horizon this positioning helps absorb earnings volatility and funds routine capex or restructuring without immediate solvency pressure.
Read all positive factors

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) vs. iShares MSCI Hong Kong ETF (EWH)

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model

Company Description
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. engages in the processing, production, distribution, and sale of hydrogenated benzene-based chemicals and energy products in the People's Republic of China. Its hydrogenated benzene-based chemicals in...
How the Company Makes Money
null...

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview

Summary
Overall financial quality is mixed: the income statement has deteriorated sharply with losses in 2024–2025 and margin compression, while the balance sheet remains moderately levered and operating cash flow stays positive. Free cash flow improved in 2024–2025 but is volatile, including a steep decline in 2025 versus 2024.
Income Statement
28
Negative
Balance Sheet
62
Positive
Cash Flow
54
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.53B3.10B2.33B2.30B1.48B
Gross Profit30.08M71.64M148.80M285.51M142.80M
EBITDA92.32M77.03M163.47M294.84M168.50M
Net Income-33.39M-16.04M54.92M138.23M72.47M
Balance Sheet
Total Assets1.52B1.68B1.66B1.08B971.94M
Cash, Cash Equivalents and Short-Term Investments357.55M352.62M300.71M92.47M50.08M
Total Debt290.06M338.27M262.97M165.30M51.17M
Total Liabilities446.60M584.85M535.95M355.88M418.55M
Stockholders Equity951.54M985.37M1.02B573.79M457.93M
Cash Flow
Free Cash Flow72.66M13.82M-43.95M199.74M44.27M
Operating Cash Flow114.76M96.86M104.46M318.82M94.88M
Investing Cash Flow-41.12M-268.86M-71.06M-150.12M-58.70M
Financing Cash Flow-68.09M2.49M204.95M-139.06M-44.28M

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.43
Price Trends
50DMA
0.49
Negative
100DMA
0.46
Positive
200DMA
0.45
Positive
Market Momentum
MACD
-0.01
Positive
RSI
43.65
Neutral
STOCH
45.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Neutral. The current price of 0.43 is below the 20-day moving average (MA) of 0.51, below the 50-day MA of 0.49, and below the 200-day MA of 0.45, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 43.65 is Neutral, neither overbought nor oversold. The STOCH value of 45.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2502.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
HK$1.38B3.773.36%7.85%-5.34%43.44%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
59
Neutral
HK$13.79B-30.56-3.24%3.48%3.39%-2.32%
58
Neutral
HK$16.55B6.7012.56%5.31%0.46%6.62%
51
Neutral
HK$912.69M-7.57-15.41%-0.05%-54.13%
48
Neutral
HK$969.97M-6.68-3.55%-16.30%-113.19%
39
Underperform
HK$1.24B-0.42-38.60%-9.38%-5783.70%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2502
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
0.61
0.22
56.41%
HK:0336
Huabao International Holdings
4.20
1.85
78.65%
HK:0408
Yip's Chemical Holdings
2.45
1.00
68.85%
HK:3318
China Boton Group Co., Ltd.
1.20
-0.40
-25.00%
HK:0546
Fufeng Group Limited
6.47
0.17
2.71%
HK:0301
SANVO Fine Chemicals Group Limited
1.99
0.77
63.11%

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events

Henan Jinyuan Hydrogenated Chemicals Sets AGM, Cancels 2025 Final Dividend
Apr 23, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has called its 2025 annual general meeting for 20 May 2026 in Hong Kong, where shareholders will review board and supervisory committee reports, audited 2025 financial statements, and the annual repor...
Henan Jinyuan Hydrogenated Chemicals Swings to Shareholder Loss on Weaker 2025 Revenue
Mar 23, 2026
Henan Jinyuan Hydrogenated Chemicals reported 2025 revenue of RMB2.60 billion, down from RMB3.10 billion a year earlier, as gross profit narrowed sharply and joint-venture performance turned negative. The group swung to a net loss attributable to ...
Henan Jinyuan Flags Wider 2025 Loss on Higher Costs and LNG Margin Squeeze
Mar 16, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has warned that it expects to post a loss of about RMB34.2 million attributable to shareholders for 2025, widening from a loss of roughly RMB15.8 million a year earlier. The company said the deteriora...
Henan Jinyuan Hydrogenated Chemicals Sets March Board Meeting on 2025 Results and Dividend
Mar 9, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has scheduled a board meeting for 23 March 2026 to review and approve the audited annual results for the year ended 31 December 2025, with plans to publish the figures on both the Hong Kong stock exch...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 30, 2026